Navigation Links
YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
Date:11/11/2009

September 30, 2009 2008 ------------------------------------------------------------------------- (Unaudited) Out-licensing revenue $ 727,538 $ 1,214,945 Interest income 19,119 442,621 ------------------------------------------------------------------------- 746,657 1,657,566 Expenses: Licensing and product development 2,436,048 3,845,184 General and administrative 1,784,432 1,147,378 ----------------------------------------------------------------------- 4,220,480 4,992,562 ------------------------------------------------------------------------- Loss before the undernoted (3,473,823) (3,334,996) Gain (loss) on foreign exchange (26,747) 12,203 Loss on short-term deposits (2,218) (140,559) Other income - 307,140 ------------------------------------------------------------------------- Loss and comprehensive loss for the period (3,502,788) (3,156,212) Deficit, beginning of period (146,251,951) (133,182,485) ------------------------------------------------------------------------- Deficit, end of period $(149,754,739) $(136,338,697) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Basic and diluted loss per common share $ (0.06) $ (0.06) -------------------------------
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), ... technologies and products for advanced microarray diagnostics, today ... CFE  to its Management team. In his capacity ... its transition from a development stage to a ... advance the Company,s capital market strategy and to ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Crown Bioscience, ... company, has launched a new Life Science division specializing ... preclinical research. , The first products released include ... controls, and soon to be released in vivo grade ... continue to expand their life science portfolio with additional ...
(Date:3/3/2015)... Milpitas, Calif. (PRWEB) March 03, 2015 ... risk management excellence were honored by the Global ... annual event which took place on Wednesday, February 25th, ... , The GSCRC was formed to bring together supply ... thought leaders to advance the professional discipline through opportunities ...
(Date:3/3/2015)... PARSIPPANY, N.J. , March 3, 2015  Thingee ... industry, will be delivering a presentation entitled, "Technology Adoption: ... Conference, Thriving through Innovations and Technology ,  in ... from March 11 to 13, 2015. Audiences looking to ... more effectively will want to be in the audience ...
Breaking Biology Technology:SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Crown Bioscience Launches Life Science Product Catalog 2Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Thingee to present at 11th Annual Synergistix Users Conference 2
... Spherix Incorporated,(Nasdaq: SPEX ) reported that ... Nasdaq advising the Company that, because of the ... enforcement of,the bid price and market value requirements ... period will be in effect from October 16,2008 ...
... Michigan,s stem,cell research initiative -- Proposal 2 -- ... reprehensible Tuskegee Experiments as a basis,for comparison to ... myths and,misinformation. Distortions about the nature and regulatory ... is important to set the facts straight., ...
... England, Oct. 23 BioWisdom Ltd (BioWisdom),the ... the,pharmaceutical industry, today announces the release of ... data are increasingly being used in competitive ... and business decisions.,OmniViz Visualization Software can turn ...
Cached Biology Technology:Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period 2Anti-Stem-Cell-Research Ad Ignores Facts 2Anti-Stem-Cell-Research Ad Ignores Facts 3
(Date:2/5/2015)... Calif. , Feb. 3, 2015 ... technology, demand from industries such as consumer electronics, ... market for surface mount technology (SMT) screen printers. ... to automatic control will push the adoption curve ... will remain steady as glue dispensers are indispensable ...
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... cow disease-testing program is wholly inadequate and the ... testing further undercuts the safety of American beef, ... meat from cattle infected with bovine spongiform encephalopathy, ... a fatal human brain-wasting disorder. More than 160 ...
... NH&MRC, industry and state governments released today by the ... up to 275 new victims each day throughout Australia. ... Lifestyle Study (AusDiab) were presented today to the Federal ... provide the first definitive, clear picture of the rising ...
... proliferation of a broad range of lethal malignant glioma ... in the May issue of Cancer Cell, shed light ... to play a role in cancer progression. This study ... must display a broad reactivity to effectively attenuate the ...
Cached Biology News:Federal testing for mad cow disease a failure, law review editor says 2Federal testing for mad cow disease a failure, law review editor says 3Federal testing for mad cow disease a failure, law review editor says 4Diabetes hits 275 Australians each day as pandemic spreads 2Diabetes hits 275 Australians each day as pandemic spreads 3Unique dual target specificity of kinase inhibitor key for success against cancer 2
... chromatographically purified from egg white. The extinction coefficient ... is in 10 mM phosphate-buffered saline, ... 0.05% sodium azide and 50% glycerol. Avidin (from ... is purified by molecular sieving and ...
Request Info...
Request Info...
... ml CELLection Dynabeads (4.5 m) coated with ... antigen EpCAM and DNase Releasing Buffer. ... epithelial tumour cells directly from blood, bone ... be enriched from bone marrow. Enriched cells ...
Biology Products: